Bicocca Open Archive

Logo unimib boa
CADAMURO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.878
AS - Asia 8.744
EU - Europa 5.818
SA - Sud America 1.214
Continente sconosciuto - Info sul continente non disponibili 619
AF - Africa 210
OC - Oceania 23
Totale 30.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.162
SG - Singapore 2.705
CN - Cina 1.870
IT - Italia 1.813
VN - Vietnam 1.487
HK - Hong Kong 1.058
RU - Federazione Russa 974
BR - Brasile 902
SE - Svezia 599
DE - Germania 564
CA - Canada 536
IE - Irlanda 451
BD - Bangladesh 340
GB - Regno Unito 307
UA - Ucraina 283
IN - India 249
KR - Corea 227
FR - Francia 223
FI - Finlandia 198
ID - Indonesia 146
AR - Argentina 120
TR - Turchia 103
IQ - Iraq 102
JP - Giappone 86
ES - Italia 77
MX - Messico 77
ZA - Sudafrica 72
PK - Pakistan 71
NL - Olanda 69
EC - Ecuador 53
AT - Austria 52
CO - Colombia 46
PL - Polonia 46
SA - Arabia Saudita 37
UZ - Uzbekistan 37
DK - Danimarca 32
VE - Venezuela 32
TW - Taiwan 28
MA - Marocco 27
PH - Filippine 27
BE - Belgio 22
EG - Egitto 20
MY - Malesia 20
CL - Cile 18
CR - Costa Rica 18
KE - Kenya 18
AU - Australia 17
CH - Svizzera 17
JO - Giordania 17
PY - Paraguay 17
TH - Thailandia 17
JM - Giamaica 16
TN - Tunisia 16
TT - Trinidad e Tobago 15
HN - Honduras 14
CZ - Repubblica Ceca 13
IL - Israele 13
LT - Lituania 13
NP - Nepal 13
DZ - Algeria 12
ET - Etiopia 12
EU - Europa 12
AE - Emirati Arabi Uniti 11
NO - Norvegia 11
GT - Guatemala 10
IR - Iran 10
LB - Libano 10
PE - Perù 9
PS - Palestinian Territory 9
RO - Romania 9
UY - Uruguay 9
AL - Albania 8
BO - Bolivia 7
AZ - Azerbaigian 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NI - Nicaragua 6
RS - Serbia 6
SN - Senegal 6
SV - El Salvador 6
BY - Bielorussia 5
NG - Nigeria 5
AM - Armenia 4
AO - Angola 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
BG - Bulgaria 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
MD - Moldavia 3
MN - Mongolia 3
PT - Portogallo 3
QA - Qatar 3
SY - Repubblica araba siriana 3
Totale 29.859
Salva come PNG Salva come JPEG
Città #
Singapore 1.610
Ashburn 1.436
Hong Kong 1.000
Ann Arbor 991
San Jose 975
Fairfield 569
Milan 560
Woodbridge 546
Ho Chi Minh City 484
Houston 472
Chandler 458
Dublin 435
New York 385
Council Bluffs 359
Hanoi 358
Toronto 355
Frankfurt am Main 321
Hefei 321
Santa Clara 305
Wilmington 282
Jacksonville 281
Los Angeles 277
Seattle 272
Beijing 262
Dallas 254
Dearborn 225
Chicago 217
The Dalles 192
Seoul 190
Cambridge 181
Rome 153
Princeton 148
Lauterbourg 123
Buffalo 112
Helsinki 111
Nanjing 107
Columbus 100
Jakarta 98
Shanghai 90
Boardman 89
São Paulo 88
Moscow 78
Guangzhou 67
Phoenix 62
Lawrence 55
Munich 55
Orem 55
Tokyo 54
Da Nang 52
Figino 51
Brooklyn 49
Atlanta 48
Hangzhou 47
Lachine 46
Baghdad 44
Montreal 43
Chennai 42
Haiphong 40
Altamura 37
London 37
Denver 36
San Diego 35
Nuremberg 33
Shenyang 33
Tashkent 32
Warsaw 31
Salt Lake City 29
Andover 27
Vienna 27
Ha Long 26
Johannesburg 26
Turin 26
Zhengzhou 26
Brasília 25
Can Tho 25
Changsha 25
Philadelphia 25
Rio de Janeiro 25
Dhaka 24
Naples 24
Fremont 23
Lappeenranta 23
Nanchang 23
Padova 23
Thái Nguyên 23
Hải Dương 22
Pune 22
Biên Hòa 21
Brussels 21
Lahore 21
Ottawa 21
Tianjin 21
Mexico City 20
Boston 19
Kunming 19
Las Vegas 19
Manchester 19
San Francisco 19
Quito 18
Washington 18
Totale 17.729
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 709
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 574
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 531
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 444
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 430
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 408
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 377
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 368
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 350
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 343
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 339
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 333
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 332
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 325
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 314
Cholangiocyte biology as relevant to cystic liver diseases 314
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 308
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 303
Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis 300
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 293
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 286
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 283
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 281
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 280
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 280
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 280
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 277
Animal models of cholestasis: An update on inflammatory cholangiopathies 276
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 273
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 272
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 270
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 268
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 266
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 265
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 264
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 263
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 263
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 262
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 261
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 261
Notch signaling and progenitor/ductular reaction in steatohepatitis 255
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 255
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 251
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 248
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 248
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 246
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 245
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 244
The patient presenting with isolated hyperbilirubinemia 241
Cholangiocarcinoma 238
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 236
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 236
Emerging concepts in biliary repair and fibrosis 236
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 235
Cholangiocarcinoma 232
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 230
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 229
Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis 224
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 221
Tumor microenvironment and immunology of cholangiocarcinoma 220
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 219
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 219
Animal models for cystic fibrosis liver disease (CFLD) 218
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 216
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 216
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 215
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 214
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 212
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 212
Role of angiogenesis and angiogenic factors for cholangiocyte growth 210
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 210
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 209
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 208
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 207
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 205
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 205
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 202
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 201
Animal models of cholangiocarcinoma: What they teach us about the human disease 201
Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma 196
Cirrosi Biliare Primitiva 196
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 195
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy 194
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 193
The healthy biliary tree: Cellular and immune biology 193
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 192
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 186
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 186
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 186
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 185
Congenital cystic lesions of the biliary tree 184
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 180
The multitasking behavior of cholangiocyte in the reaction to liver damage 177
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 174
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 174
Colangite Sclerosante Primitiva 168
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 168
Cancer-associated thrombosis in cholangiocarcinoma: Exploring a phenotype of tumor aggressiveness 167
Oxidative Stress in Non-Autoimmune Liver Diseases 166
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 163
Totale 25.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 0 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20254.715 275 532 334 175 388 221 229 203 366 706 504 782
2025/202612.277 1.605 1.103 781 1.188 1.158 598 1.523 534 888 1.116 831 952
2026/20273.520 527 802 1.496 695 0 0 0 0 0 0 0 0
Totale 30.506